Document:

EX-10.21

 Exhibit 10.21 

ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT 

This assignment, assumption and amendment agreement (the “Agreement”) is dated January 3, 2022 among Bausch Health Companies Inc., a
corporation a corporation incorporated under the British Columbia Business Corporations Act (the “Assignor”), Bausch + Lomb Corporation, a company incorporated under the laws of Canada (the “Assignee”) and Joseph F.
Gordon (the “Executive”) (the “Parties”, and each a “Party”). 
 RECITALS: 

 

	 	(a)	 The Assignor and the Executive are parties to the Executive Employment Agreement dated as of
August 2, 2018 (the “Employment Agreement”). 

  

	 	(b)	 The Board of Directors of the Assignor (the “Board”) has determined that it is in the best
interests of Assignor and its stockholders to separate the Assignee’s business from the remainder of the Assignor by providing for an initial public offering of the Assignee’s stock (the “IPO”) and subsequently separating
the Assignee’s business from the Assignor. 

  

	 	(a)	 In connection with the IPO, the Assignor intends to assign all of its rights, title and interest in and to the
Employment Agreement to the Assignee. 

  

	 	(b)	 The Assignee intends to assume all of the obligations and liabilities of the Employment Agreement from the
Assignor. 

  

	 	(c)	 The Parties desire to amend the Employment Agreement as set forth herein. 

 

	 	(d)	 This Agreement shall be effective as of the date of the closing of the IPO (the “IPO Closing
Date”), subject to the closing of the IPO. 

  

	 	(e)	 Capitalized terms used herein but not defined shall have the meaning ascribed thereto in the Employment
Agreement. 

 In consideration of the above and for other good and valuable consideration, including, the Executive’s employment in a
new role with the Assignee, the Parties hereto agree as follows: 
 Section 1 Amendment of the Employment Agreement 

The Parties hereto hereby agree that the Employment Agreement shall be amended as follows, effective as of the IPO Closing Date, subject to the closing of the
IPO: 
  

	 	(a)	 Company. All references to the “Company” shall instead refer to Bausch + Lomb
Corporation, a company incorporated under the laws of Canada. 

  

	 	(b)	 Records and Confidential Data. 

 

	 	a.	 The following sentence shall be added to the end of Section 12(d) of the Employment Agreement:

 “For purposes of this Section 12(d), all references to the “Company and its affiliates” shall be
deemed to include each of the Company, Bausch Health Companies Inc. (together with any successor thereto) (“BHC”), Solta Medical Corporation (together with any successor thereto) (“Solta”) and each of their
respective subsidiaries and affiliates.” 
  

	 	(c)	 Covenant Not to Solicit. 

 

	 	a.	 The first sentence of Section 13(a) of the Employment Agreement shall be amended and restated in its
entirety and replaced with the following: 

 “To protect the Confidential Information, Company Intellectual Property
(as defined below) and other trade secrets of the Company and its affiliates, Executive agrees that during the Employment Term and for a period of twelve (12) months after Executive’s cessation of employment with the Company (the
“Restricted Period”), not to solicit, hire or participate in or assist in any way in the solicitation or hire of any Covered Employees (as defined below).” 

 

	 	b.	 The first sentence of the second paragraph of Section 13(a) of the Employment Agreement shall be amended
and restated in its entirety and replaced with the following: 

 “In addition, to protect the Confidential
Information, Company Intellectual Property and other trade secrets of the Company and its affiliates, Executive agrees that during the Employment Term and the Restricted Period, not to (x) solicit any Covered Person to receive services or to
purchase any good or services in competition with those provided by the Company or any of its subsidiaries or (y) interfere or attempt to interfere in any material respect with the relationship between BHC, Solta, the Company or any of their
respective subsidiaries or affiliates (as applicable) on one hand and any Covered Person on the other hand.” 
  

	 	c.	 The following sentence shall be added to the end of Section 13(a) of the Employment Agreement:

 “For purposes of this covenant, (i) “Covered Employee” means (A) during the period ending on
the date that is 12 months after the IPO Closing Date, (x) any employee of BHC, Solta, the Company or any of their respective subsidiaries or affiliates (including, for the avoidance of doubt, with respect to the Company’s global eye
health business (the “B+L Business”) or the global aesthetics medical device business) or (y) any person who was an employee of BHC, Solta, the Company or any of their respective subsidiaries or affiliates during the six-month period preceding such action and (B) at any time following the end of the period described in clause (A), any employee of (x) the Company or any of its subsidiaries or affiliates or the B+L
Business (including, for the avoidance of doubt, if employed by BHC or Solta or any of their subsidiaries or affiliates in the B+L Business) or (y) any person who was an employee of the Company or any of its subsidiaries or affiliates or the
B+L Business (including by BHC or Solta), in each case during the six-month period preceding such action and (ii) “Covered Person” means (A) during the period ending on the date that is
12 months after the IPO Closing Date, any client, customer, supplier, investor, financing source or capital market intermediary of BHC, Solta, the Company or any of their respective subsidiaries or affiliates (including, for the avoidance of doubt,
with respect to the B+L Business) and (B) at any time following the end of the period described in clause (A), any client, customer, supplier, investor, financing source or capital market intermediary of the Company, any of its subsidiaries or
affiliates or the B+L Business.” 

  
 - 2 - 

	 	(d)	 Covenant Not to Compete. 

 

	 	a.	 The first sentence of Section 13(b) of the Employment Agreement shall be amended and restated in its
entirety and replaced with the following: 

 “To protect the Confidential Information, Company Intellectual Property
(as defined below) and other trade secrets of the Company and its affiliates, Executive agrees (i) during the period beginning on the date hereof and ending on the date that is 12 months after the IPO Closing Date, or the last day of the
Restricted Period, if earlier (such period, the “First Period”), not to engage in Prohibited Activities (as defined below) in any country in which the Company, BHC, Solta or any of their affiliates conducts business, or plans to
conduct business, and (ii) following the expiration of the First Period, during the Employment Term and the Restricted Period (the “Second Period”), Executive agrees not to engage in Prohibited Activities in any country in
which the Company or any of its affiliates conducts business, or plans to conduct business. For the purposes of this Agreement, the term “Prohibited Activities” means directly or indirectly engaging as an owner, employee, partner,
member, consultant or agent of any entity that derives more than 10% of its consolidated revenue from the development, manufacturing, marketing and/or distribution (directly or indirectly) of (x) during the First Period, branded or generic
prescription or non-prescription pharmaceuticals or medical devices for treatments in the fields of neurology, dermatology, gastroenterology, ophthalmology or dentistry (including, for the avoidance of doubt,
the global eye health business and the global aesthetics medical device business) and (y) during the Second Period, the global eye health business; provided that Prohibited Activities shall not mean Executive’s investment in
securities of a publicly-traded company equal to less than five (5%) percent of such company’s outstanding voting securities and provided further that, for the avoidance of doubt, Executive complies with the obligations set forth
in Sections 12, 13(a) and 13(c) of this Agreement. 
  

	 	(e)	 Remedies for Breach of Obligations under Sections 12 or 13 hereof. The following is added to the end of
Section 14 of the Employment Agreement: 

 “Executive agrees and acknowledges that BHC shall at all times
following the date hereof have the right to enforce, and be an express third-party beneficiary hereunder with respect to, Executive’s obligations under Section 12 and Section 13 of this Agreement and, accordingly, that BHC shall have
all of the rights and remedies (including to the right to obtain injunctive relief against any breach or prospective breach of such obligations by Executive) as are afforded under this Agreement to the Company.” 

Section 2 Assignment. 
 Effective as of and from
the IPO Closing Date, subject to the occurrence of the closing of the IPO, the Assignor hereby assigns to the Assignee all of the Assignor’s rights, title and interest in and to, and all benefits of the Assignor under, the Employment
Agreement. In the event the closing of the IPO does not occur for any reason, this Agreement will be null and void and of no force or effect and the Employment Agreement will continue in effect in accordance with its terms without giving effect to
this Agreement. 
 Section 3 Assumption by Assignee. 

Effective as of and from the IPO Closing Date, subject to the occurrence of the closing of the IPO, the Assignee hereby assumes and agrees to perform
and discharge all the obligations and liabilities of the Assignor under the Employment Agreement, and accordingly the Parties agree that as and from the IPO Closing Date, the term the “Company” under the Employment Agreement shall
refer to the Assignee except as otherwise set forth in this Agreement. 

  
 - 3 - 

 Section 4 Further Assurances. 

On or after the date of this Agreement, each Party hereto shall execute and deliver such documents and take all such action as is reasonably required to carry
out the intent and purpose of this Agreement. Except as specifically amended and supplemented hereby, the Employment Agreement shall remain in full force and effect in accordance with its terms. 

Section 5 Successors and Assigns. 
 This Agreement
shall be binding upon and shall inure to the benefit of the Parties hereto, their successors and permitted assigns and the Parties shall require any successor or assign to expressly assume and agree to perform this Agreement in the same manner and
to the same extent that the applicable Party would be required to perform if no such succession or assignment had taken place. The Parties may not assign or delegate any rights or obligations hereunder except to a successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Party, as applicable. 
 Neither
this Agreement nor any right or interest hereunder shall be assignable or transferable by the Executive, the Executive’s beneficiaries or legal representatives, except by will or by the, laws of descent and distribution. 

This Agreement shall inure to the benefit of and be enforceable by the Executive’s legal personal representatives. 

Section 6 No Third Party Beneficiaries. 
 The
Parties hereto shall have the sole right to enforce the performance of the provisions of this Agreement. Except for the Parties hereto or as expressly contemplated by Section 1(e) of this Agreement, this Agreement is not intended for the
benefit of, and is not intended to be relied upon by, any other person and no such person (or any other person acting on its behalf) shall be entitled to the benefit of or to enforce this Agreement. 

Section 7 Amendment and Waiver. 
 No provision of
this Agreement may be altered, amended and/or waived except by a written document signed by all Parties hereto setting forth such alteration, amendment, and/or waiver. The Parties hereto agree that the failure to enforce any provision or obligation
under this Agreement shall not constitute a waiver thereof or serve as a bar to the subsequent enforcement of such provision or obligation or any other provisions or obligations under this Agreement. No course of dealing between or among any persons
having any interest in this Agreement will be deemed effective to modify or amend any part of this Agreement or any rights or obligations of any person under or by reason of this Agreement. 

Section 8 Severability. 
 The provisions of this
Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. 

  
 - 4 - 

 Section 9 Governing Law. 

This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New Jersey applicable to contracts executed in and
to be performed entirely within such State, without giving effect to the conflict of law principles thereof. 
 Section 10 Counterparts. 

This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the
same instrument. 
 [Signature page follows] 

  
 - 5 - 

 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day and year first written above.

  

			
	BAUSCH HEALTH COMPANIES INC.
		
	By:	 	 /s/ Joseph C. Papa

		 	Name: Joseph C. Papa
		 	Title: Chief Executive Officer
	
	BAUSCH + LOMB CORPORATION
		
	By:	 	 /s/ Kelly Webber

		 	Name: Kelly Webber
		 	Title: Executive Vice President and Chief Human Resources Officer
	
	JOSEPH F. GORDON
	
	 /s/ Joseph F. Gordon

 [Signature Page to Assignment, Assumption and Amendment Agreement – Employment Agreement]

  
 - 6 -EX-10.22

 Exhibit 10.22 

BAUSCH + LOMB CORPORATION 

FORM OF STOCK OPTION GRANT AGREEMENT 

(NONSTATUTORY STOCK OPTION – FOUNDER GRANT) 

(2022 Omnibus Incentive Plan) 
 Bausch +
Lomb Corporation (the “Company”), pursuant to Section 7(a) of the Company’s 2022 Omnibus Incentive Plan (the “Plan”), hereby grants to you an Option to purchase the number of Common Shares
set forth below (the “Option” or the “Award”). This Award is subject to all of the terms and conditions as set forth herein (the “Agreement”) and in the Plan, which is
incorporated herein in its entirety. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Plan. In the event of any conflict between the terms in the Agreement and the Plan, the terms of the Plan shall control. For
the avoidance of doubt, any terms contained in the Agreement but are not in the Plan shall not constitute a conflict and such terms in the Agreement shall control. 

 

			
	Option Holder:	  	 [•]

	Grant Date:	  	 [•]

	Number of Common Shares Subject to Option:	  	 [•]

	Exercise Price (Per Share):	  	 [•]

	Expiration Date:	  	 [•]

  

			
	Type of Grant:	  	☐ Nonstatutory Stock Option
		
	Exercise Schedule:	  	Same as Vesting Schedule
		
	Vesting Schedule:	  	This Award shall vest in accordance with the following vesting
		
		  	schedule, provided that you are employed by the Company or one of its Subsidiaries on the applicable Vesting Date (as defined below):
		
		  	— 1/3 of the Common Shares subject to the Option vest on the later of (A) the first anniversary of the Grant Date and (B) the earlier of (1) the Distribution
Date and (2) the date of a Change of Control (such applicable date, the “First Vesting Date”).
		
		  	— 1/3 of the Common Shares subject to the Option vest on the later of (A) the second anniversary of the Grant Date and (B) the earlier of (1) the Distribution
Date and (2) the date of a Change of Control (such applicable date, the “Second Vesting Date”).
		
		  	— 1/3 of the Common Shares subject to the Option vest on the later of (A) the third anniversary of the Grant Date and (B) the earlier of (1) the Distribution
Date and (2) the date of a Change of Control (such applicable date, the “Third Vesting Date” and, together with the First Vesting Date and the Second Vesting Date, each a “Vesting
Date”).
		
		  	— For the avoidance of doubt, in no event shall the Option vest or be exercisable following the tenth anniversary of the Grant Date.
		
		  	— For purposes of this Agreement, the Distribution Date has the meaning set forth in the Employee Matters Agreement.

			
	Payment:	  	By one or a combination of the following methods of payment (described in the Agreement):
		
		  	 ☐   Cash or check

		
		  	 ☐   Bank draft or money order payable to the Company

		
		  	 ☐   Pursuant to a Regulation T program (cashless exercise) if the shares
are publicly traded

		
		  	 ☐   Delivery of already-owned shares if the shares are publicly
traded

		
		  	 ☐   Net exercise

 The details of your Award are as follows: 

1. VESTING. 

(a) In General. Subject to the provisions of the Plan and the limitations contained herein, your Award will vest as provided
above; provided you are employed by the Company or one of its Subsidiaries through the applicable Vesting Date [and continue to comply with the restrictive covenants in Sections 11 and
12]1; provided that vesting will cease upon your Termination of Service (except as set forth below in Section 1(b) through (d)), and any unvested portion of your Option will be
forfeited (and, in the case of your Termination of Service for Cause, the vested portion of your Option will also be forfeited). 

(b) Vesting Acceleration Upon Termination of Service due to Death or Disability. Notwithstanding the foregoing and any other
provisions of the Plan to the contrary, in the event of your Termination of Service by the Company due to your death or Disability, then any unvested portion of your Option will vest on the date of your Termination of Service. 

(c) Vesting Acceleration Upon Termination of Service without Cause [or for Good Reason]2 in Connection with a Change of Control. Notwithstanding the foregoing and any other provisions of the Plan to the contrary, in the event of your Termination of Service [(x)] by the Company
without Cause [or (y) by you for Good Reason][, in either case] within twelve (12) months following a Change of Control (or during the six month period prior to a Change of Control if such Termination of Service was in contemplation of,
and directly related to, the Change of Control), then any unvested portion of your Option that was not cancelled in connection with such Change of Control in exchange for a cash payment will vest on the date of your Termination of Service,
conditioned on you delivering to the Company, and failing to revoke, a signed release of claims acceptable to the Company within fifty-five (55) days following the date of your Termination of Service.  

2. NUMBER OF SHARES AND EXERCISE
PRICE. The number of Common Shares subject to your Option and your exercise price per share referenced above may be adjusted from time to time in accordance with Section 6(e) of the Plan. 

 
  

	1 	 To be included as applicable. 

	2 	 To be included as applicable. 

 3. METHOD OF
PAYMENT. Payment of the exercise price is due in full upon exercise of all or any part of your Option. You may elect to make payment of the exercise price of your Option in cash or by check or in any other manner
permitted by the Company, which may include one or more of the following: 
 (a) Bank draft or money order payable to the Company.

 (b) Provided that at the time of exercise the Common Shares are publicly traded and quoted regularly in The Wall Street
Journal, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Shares, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable
instructions to pay the aggregate exercise price to the Company from the sales proceeds. 
 (c) Provided that at the time of exercise
the Common Shares are publicly traded and quoted regularly in The Wall Street Journal, by delivery to the Company (either by actual delivery or attestation) of already-owned Common Shares either that you have held for the period required to
avoid a charge to the Company’s reported earnings (generally six (6) months) or that you did not acquire, directly or indirectly from the Company, that are owned free and clear of any liens, claims, encumbrances or security interests, and
that are valued at Market Price on the date of exercise. “Delivery” for these purposes, in the sole discretion of the Company at the time you exercise your Option, shall include delivery to the Company of your attestation of
ownership of such Common Shares in a form approved by the Company. Notwithstanding the foregoing, you may not exercise your Option by tender to the Company of Common Shares to the extent such tender would violate the provisions of any law,
regulation or agreement restricting the redemption of the Company’s stock. 
 (d) By a “net exercise” arrangement
pursuant to which the Company will reduce the number of Common Shares issued upon exercise of your Option by the largest whole number of Common Shares with a Market Price that does not exceed the aggregate exercise price; provided, however,
that the Company shall accept a cash or other payment from you to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole Common Shares to be issued; provided further, however,
that Common Shares will no longer be outstanding under your Option and will not be exercisable thereafter to the extent that (i) Common Shares are used to pay the exercise price pursuant to the “net exercise,” (ii) Common
Shares are delivered to you as a result of such exercise, and (iii) Common Shares are withheld to satisfy tax withholding obligations. 

4. WHOLE SHARES. You may exercise your Option only for whole Common Shares. 

5. SECURITIES LAW COMPLIANCE. Notwithstanding anything to the
contrary contained herein, you may not exercise your Option unless the Common Shares issuable upon such exercise are then registered under the Securities Act of 1933, as amended (the “Securities Act”) or if such Common Shares are
not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act. The exercise of your Option must also comply with other applicable laws and regulations
governing your Option, and you may not exercise your Option if the Company determines that such exercise would not be in material compliance with such laws and regulations. 

 6. TERM. You may not exercise your Option before
it becomes vested and exercisable or after the expiration of its term. The term of your Option commences on the Grant Date and, except as provided otherwise in Section 7(a) of the Plan, expires upon the earliest of the following: 

(a) the Expiration Date indicated above; 

(b) your Termination of Service, in the event of your Termination of Service for Cause; 

(c) three (3) months following your Termination of Service by the Company without Cause [or by you for Good Reason]3; 
 (d) six (6) months following your Termination of Service by the Company due
to your death or Disability, or upon the expiration of your employment term following a notice of non-renewal of your Service Agreement by the Company; or 

(e) three (3) months following your Termination of Service for any reason other than those specifically enumerated in this
Section 6; provided, however, that (i) if, during any part of the three (3) month or six (6) month periods set forth in Section 6(c) or (d), respectively, your Option is not exercisable solely because of the condition
set forth in Section 5, your Option shall not expire until the earlier of the Expiration Date or until it shall have been exercisable for an aggregate period of three (3) months or six (6) months after your Termination of Service, as
applicable (provided that in no event shall your Option be exercisable at any time following the Expiration Date). 
 7.
EXERCISE. You may exercise the vested portion of your Option during its term by delivering a notice (in a form designated by the Company) together with the exercise price to the Company’s Plan
administrator, or to such other person as the Company may designate, during regular business hours, together with such additional documents as the Company may then require. 

8. TRANSFERABILITY. 

(a) Restrictions on Transfer. Your Option shall not be transferable except by will or by the laws of descent and distribution and
shall be exercisable during your lifetime only by you; provided, however, that the Board may, in its sole discretion, permit you to transfer your Option in a manner consistent with applicable tax and securities laws upon your request. 

(b) Domestic Relations Orders. Notwithstanding the foregoing, your Option may be transferred pursuant to a domestic relations
order. 
  
  

	3 	 To be included as applicable. 

 (c) Beneficiary Designation. Notwithstanding the foregoing, you may, by
delivering written notice to the Company, in a form provided by or otherwise satisfactory to the Company, designate a third party who, in the event of your death, shall thereafter be entitled to exercise your Option. 

9. CHANGE OF CONTROL. Upon the occurrence of a Change of Control, at
the election of the Committee in its discretion, your Option shall either be (i) cancelled in exchange for a payment in cash, securities, rights and/or other property, in an amount equal to the value of the Option, which shall be determined by
reference to (A) in the case of any merger transaction, the consideration received by holders of Common Shares in the transaction constituting the Change of Control or (B) in the case of any other event that constitutes a Change of
Control, the Market Price of a Common Share on the date such Change of Control occurs (in each case, minus the applicable exercise price per Common Share) or (ii) converted into an option in respect of the common stock of the acquiring
or surviving entity (or its parent) (in a merger or otherwise) on the basis of the relative values of such stock and the Common Shares at the time of the Change of Control; provided that clause (ii) shall only be applicable if the common
stock of the acquiring or surviving entity (or its parent), as applicable, is publicly traded on an established securities market on the date on which such Change of Control is effected. 

10. DISCLOSURE AND OWNERSHIP OF INTELLECTUAL
PROPERTY. 
 (a) Company Intellectual Property. You acknowledge and agree that any intellectual property,
including, without limitation, works, materials, inventions, invention disclosures, invention registrations, patent rights, trademarks, service marks, trade names, trade dress, logos, domain names, copyrights, design rights, mask works, software,
apparatus, technology, data, trade secrets, know-how and all other intellectual property and proprietary rights recognized by any applicable law of any jurisdiction, that you create, discover, conceive, reduce
to practice, develop or acquire during the course of your employment, either alone or jointly with others, (i) using any equipment, supplies, facilities, trade secrets, know-how or other Confidential
Information of the Company or any of its affiliates, (ii) that results from any work performed for the Company or any of its affiliates and/or (iii) that otherwise relates to the Company’s or any of its affiliates’ business or
actual or demonstrably anticipated research or development (collectively, “Company Intellectual Property”) is and shall remain the exclusive property of the Company or the affiliate of the Company, as applicable, that is your
employer (the “Employer”) whether registered or otherwise exploited or not. In furtherance of the foregoing, you hereby assign, transfer, convey and deliver to the Employer your entire right, title and interest in and to any and all
such Company Intellectual Property. 
 (b) Work Made for Hire. You acknowledge and agree that, with respect to any Company
Intellectual Property that may qualify as a Work Made For Hire as defined in 17 U.S.C. § 101 or other applicable law, such Company Intellectual Property is and will be deemed a Work Made for Hire and the Employer will have the sole and
exclusive right to the copyright (or, in the event that any such Company Intellectual Property does not qualify as a Work Made for Hire, the copyright and all other rights thereto are hereby automatically assigned to the Employer as above). 

 (c) Disclosure. You agree to record all activities undertaken in the course of
your employment and to disclose promptly in writing to the Employer any and all Company Intellectual Property. You agree that you will give the Company or any of its affiliates all reasonable assistance and execute all documents necessary to assist
with enabling the Company or any of its affiliates to prosecute, perfect, register, record, enforce and defend any and all of their rights in and to any Company Intellectual Property and Confidential Information. 

(d) Non-Assignable Inventions. If your principal work location is in California,
Illinois, Kansas, Minnesota or Washington State, the provisions regarding your assignment of Company Intellectual Property to the Employer in Sections 10(a) and (b) of this Agreement may not apply to certain inventions (“Non-Assignable Inventions”) as specified in the statutory code of the applicable state. You acknowledge having received notification regarding such Non-Assignable
Inventions pursuant to such states’ codes. 
 (e) Prior Intellectual Property. If, in the course of your employment with
the Employer, you use any intellectual property that is solely or jointly owned by you or licensed to you, with the right to sub-license (collectively, “Prior Intellectual Property”), you
hereby grant to the Company and its affiliates a worldwide, non-exclusive, irrevocable, perpetual, fully paid-up and royalty-free license (with rights to sublicense
through multiple tiers of sublicensees) to use, reproduce, modify, make derivative works of, publicly perform, publicly display, make, have made, sell, offer for sale, import and otherwise exploit such Prior Intellectual Property for any purpose.

 (f) Waiver of Moral Rights. To the extent you may do so under applicable law, you hereby waive and agree never to assert any
Moral Rights that you may have in or with respect to any Company Intellectual Property, even after termination of any work on behalf of the Company or its affiliates. As used in this Agreement, “Moral Rights” means any rights to
claim authorship of a work, to object to or prevent the modification or destruction of a work, or to withdraw from circulation or control the publication or distribution of a work, and any similar right, existing under any applicable law of any
jurisdiction, regardless of whether or not such right is denominated or generally referred to as a “moral right.” 
 (g)
This Section 10 shall survive your Termination of Service. 
 11. RECORDS AND
CONFIDENTIAL DATA. In consideration of the Stock Options issued to you pursuant to this Agreement, you agree to be bound by the covenant of confidentiality set forth in this Section 11 with respect to any and
all Confidential Information (as defined below) disclosed or made available to you or of which you have otherwise become aware, whether before, on or after the date hereof. 

(a) Ownership; Recognition of Company’s Rights. You acknowledge that in connection with the performance of your duties, the
Company will make available to you, or you will have access to, certain Confidential Information of the Company and its affiliates. You acknowledge and agree that any and all Confidential Information you learned or obtained during the course of your
employment or service by the Company or any of its affiliates or otherwise, whether developed by you alone or in conjunction with others or otherwise, shall be and is the sole and exclusive property of the Employer. No license or other right to any
Confidential Information is granted to you under this Agreement. To the extent that you acquire any right, title or interest in or to any Confidential Information, you hereby assign, transfer, convey and deliver to the Employer all such right, title
and interest in and to such Confidential Information. 

 (b) Restrictions. You (i) will keep all Confidential Information strictly
confidential, (ii) will not use Confidential Information in any manner which is detrimental to the Company or its affiliates, (iii) will not use Confidential Information other than in connection with the discharge of your duties to the
Company and its affiliates, (iv) will safeguard any and all Confidential Information from unauthorized disclosure, and (v) will not disclose, publish, use, transfer or otherwise disseminate any Confidential Information to any person or
entity without the Employer’s express prior written consent, except as may be necessary to perform your duties as an employee of the Company or its affiliates for the benefit of the Company or its affiliates. You may, however, disclose
Confidential Information to the extent it is in response to a valid order of a court or other governmental authority or to otherwise comply with applicable law; provided that, subject to Section 11(e), you shall first give notice to the
Employer and reasonably cooperate with the Employer to obtain a protective order or other measures preserving the confidential treatment of such Confidential Information and requiring that the information or documents so disclosed be used only for
the purposes for which the order was issued or is otherwise required by applicable law. 
 (c) Disposition of Confidential
Information. Following your Termination of Service or upon the Company’s request, you will return to the Company all copies of any and all Confidential Information in your custody, possession or control (including all copies of any
analyses, compilations, studies or other documents prepared by you or for your use containing or reflecting any Confidential Information). Alternatively, with the Company’s prior written consent, you may destroy such Confidential Information.
Within five (5) business days of your Termination of Service or such request by the Company, you shall deliver to the Company a document certifying that such written Confidential Information has been returned or destroyed in accordance with
this Section 11(c). 
 (d) Confidential Information. For the purposes of this Agreement, “Confidential
Information” shall mean any and all non-public, proprietary or other confidential information of the Company or its affiliates disclosed to you, to which you have access, or of which you otherwise
become aware, in each case whether in oral, written, graphic or machine readable form, including, without limitation, (i) know-how, trade secrets, inventions, discoveries, concepts, information, works,
materials, processes, methods, data, software, programs, apparatus, designs and the like, and any other intellectual property the value of which is contingent upon maintaining the confidentiality thereof, (ii) information regarding the business
of the Company or its affiliates, including its products, services, budgets, contracts, reports, investigations, experiments, research, work in progress, drawings, designs, plans, proposals, codes, marketing and sales programs, client lists, client
mailing lists, supplier lists, financial projections, cost summaries, pricing formulae, marketing studies relating to prospective business opportunities, and all other concepts, ideas, materials, or information prepared or performed for or by the
Company or its affiliates, (iii) information regarding the skills and compensation of the employees, contractors, and any other service providers of the Company or its affiliates, (iv) the existence of any business discussions,
negotiations, or agreements between the Company or its affiliates and any third party, (v) all documents and other work product generated by you which 

 
contain, comment upon, or relate in any way to any information disclosed by the Company or its affiliates, (vi) all third-party information held in confidence by the Company or its
affiliates, and (vii) the terms and conditions of this Agreement. For purposes of this Agreement, the Confidential Information shall not include and your obligation shall not extend to (i) information which is generally available to the
public and (ii) information obtained by you other than pursuant to or in connection with your employment. 
 (e) Defend Trade
Secrets Act. Pursuant to Section 7 of the Defend Trade Secrets Act of 2016 (which added 18 U.S.C. § 1833(b)), you and the Company acknowledge and agree that you shall not have criminal or civil liability under any federal or state
trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, State, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting
or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition and without limiting the preceding sentence, if you file a
lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the trade secret to your attorney and may use the trade secret information in the court proceeding, if you (x) file any document containing the
trade secret under seal and (y) do not disclose the trade secret, except pursuant to court order. Nothing in this Agreement is intended to conflict with 18 U.S.C. §1833(b) or create liability for disclosures of trade secrets that are
expressly allowed by such Section. 
 (f) Whistleblower Protections. Without limiting the generality of the foregoing, nothing
in this Agreement precludes or otherwise limits your ability to (A) communicate directly with and provide information, including documents, not otherwise protected from disclosure by any applicable law or privilege to the Securities and
Exchange Commission (the “SEC”) or any other federal, state or local governmental agency or commission (“Government Agency”) or self-regulatory organization regarding possible legal violations, without
disclosure to the Company, or (B) disclose information which is required to be disclosed by applicable law, regulation, or order or requirement (including without limitation, by deposition, interrogatory, requests for documents, subpoena, civil
investigative demand or similar process) of courts, administrative agencies, the SEC, any Government Agency or self-regulatory organizations, provided that you provide the Company with prior notice of the contemplated disclosure and cooperates with
the Company in seeking a protective order or other appropriate protection of such information. The Company may not retaliate against you for any of these activities. 

(g) This Section 11 shall survive your Termination of Service. 

12. COVENANT NOT TO SOLICIT, NOT TO
COMPETE AND NOT TO DISPARAGE. In consideration of the Options issued to you pursuant to this Agreement, you agree to be bound by the covenants of non-solicitation, non-competition and non-disparagement set forth in this Section 12. 

 (a) Covenant Not to Solicit. To protect the Confidential Information and other trade
secrets of the Company and its affiliates, you agree, during your employment and for a period of twelve (12) months thereafter (or, if greater, the period set forth in your Service Agreement) not to solicit, hire or participate in or assist in
any way in the solicitation or hire of any employees of the Company or any of its Subsidiaries (or any person who was an employee of the Company or any of its Subsidiaries during the 6-month period preceding
such action). For purposes of this covenant, “solicit” or “solicitation” means directly or indirectly influencing or attempting to influence employees of the Company to become employed with any other person, partnership, firm,
corporation or other entity. You agree that the covenants contained in this Section 12(a) are reasonable and desirable to protect the Confidential Information of the Company and its affiliates, provided that solicitation through
general advertising or the provision of references shall not constitute a breach of such obligations. 
 (b) Covenant Not to
Compete. To protect the Confidential Information and other trade secrets of the Company and its affiliates, you agree, during the period of your employment and for a period of twelve (12) months thereafter (or, if greater, the period set
forth in your Service Agreement), not to engage in Prohibited Activities (as defined below) in any country in which the Company or its affiliates conduct business, or plan to conduct business, during the period of your employment. For the purposes
of this Agreement, the term “Prohibited Activities” means directly or indirectly engaging as an owner, employee, consultant or agent of any entity that derives more than 10% of its consolidated revenue from the development,
manufacturing, marketing and/or distribution (directly or indirectly) of the global eye health business; provided that Prohibited Activities shall not mean (i) your investment in securities of a publicly-traded company equal to less than
five (5%) percent of such company’s outstanding voting securities or (ii) serving as a member of a board of directors of a company provided that, for the avoidance of doubt, you comply with the obligations set forth in Sections 11 and
12(a) of this Agreement. You agree that the covenants contained in this Section 12(b) are reasonable and desirable to protect the Confidential Information of the Company and its affiliates. 

(c) Non-Disparagement Covenant. You agree not to make written or oral statements about
the Company or its affiliates or their directors, executive officers or non-executive officer employees that are negative or disparaging. The Company and its affiliates shall not, and the Company and its
affiliates shall instruct their directors and executive officers to not, make written or oral statements about you that are negative or disparaging. Notwithstanding the foregoing, nothing in this Agreement shall preclude you, the Company and its
affiliates, and the Company’s or any of its affiliate’s directors and executive officers from communicating or testifying truthfully to the extent required by law to any federal, state, provincial or local governmental agency or in
response to a subpoena to testify issued by a court of competent jurisdiction. 
 (d) Your obligations under this Section 12
shall survive your Termination of Service. 
 13. SEVERABILITY OF RESTRICTIVE
COVENANTS. It is the intent and desire of you and the Company that the restrictive provisions of this Agreement be enforced to the fullest extent permissible under the laws and public policies as
applied in each jurisdiction in which enforcement is sought. If any particular provision of Section 11 or 12 shall be determined to be invalid or unenforceable, such provision shall be amended, without any action on the part of either party
hereto, to delete therefrom the portion so determined to be invalid or unenforceable, such deletion to apply only with respect to the operation of such covenant in the particular jurisdiction in which such adjudication is made. Any provision of
Section 11 or 12 (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner that will give effect to the terms of such Section or part of such Section to the fullest extent possible while
remaining lawful and valid. 

 14. REMEDIES FOR BREACH
OF OBLIGATIONS UNDER SECTIONS 11 AND 12. You acknowledge that the Company will suffer irreparable injury, not readily susceptible of valuation in monetary damages, if you
breach any obligation under Sections 11 or 12. Accordingly, you agree that the Company will be entitled, in addition to any other available remedies, to obtain preliminary and permanent injunctive relief against any breach or prospective breach by
you of your obligations under Sections 11 or 12. Without limiting other forms of relief available to Company, in the event of your breach of any of your obligations under Sections 11 or 12, your Award will be forfeited for no consideration and, if
payment in respect of your Award has been made, you will be obligated to return the proceeds to the Company. You agree that process in any or all of those actions or proceedings may be served by registered mail, addressed to the last address
provided by you to the Company, or in any other manner authorized by law. 
 15. CLAWBACK. This Agreement is
subject to Section 12 of the Plan and any policy the Company adopts regarding the recovery of incentive compensation and any additional clawback provisions as required by law and applicable listing rules. 

16. OPTION NOT A SERVICE CONTRACT. Your
Option is not an employment or service contract, and nothing in your Option will be deemed to create in any way whatsoever any obligation on your part to continue in the service of the Company or an affiliate, or on the part of the Company or an
affiliate to continue such service. In addition, nothing in your Option will obligate the Company or an affiliate, their respective shareholders, boards of directors or employees to continue any relationship that you might have as an employee of the
Company or an affiliate. 
 17. COMMON SHARE OWNERSHIP
REQUIREMENTS. You agree to comply with, and be subject to the terms of, any Common Share ownership requirements adopted by the Company applicable to you, which shall be on the same terms as similarly situated
executives of the Company. 
 18. WITHHOLDING OBLIGATIONS. 

(a) At the time you exercise your Option, in whole or in part, or at any time thereafter as requested by the Company, you hereby
authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a “cashless exercise” pursuant to a program developed under Regulation T as promulgated by
the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company, if any, which arise in connection with the exercise of your Option.

 (b) The Company shall withhold from fully vested Common Shares otherwise issuable to you upon the exercise of your Option a number
of whole Common Shares having a Market Price, determined by the Company as of the date of exercise, equal to an amount up to the maximum amount of tax that can be withheld by law (or such other amount as may be permitted by applicable law and
accounting standards). Any adverse consequences to you arising in connection with such share withholding procedure shall be your sole responsibility. 

 19. NOTICES. Any notices provided for in your
Option or the Plan shall be given in writing and shall be deemed effectively given upon your receipt or, in the case of notices delivered by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed
to you at the last address you provided to the Company. 
 20. HEADINGS. The headings of the
Sections in this Agreement are inserted for convenience only and shall not be deemed to constitute a part of this Agreement or to affect the meaning of this Agreement. 

21. AMENDMENT. Nothing in this Agreement shall restrict the Committee’s (or its applicable
delegate’s) ability to exercise its discretionary authority pursuant to Section 4 of the Plan; provided, however, that no such action may, without your consent, adversely affect your rights under your Option. Without limiting the
foregoing, the Board (or appropriate committee thereof) reserves the right to change, by written notice to you, the provisions of this Agreement in any way it may deem necessary or advisable to carry out the purpose of the grant as a result of any
change in applicable laws or regulations or any future law, regulation, ruling, or judicial decision; provided that any such change will be applicable only to rights relating to that portion of the Award which is then subject to restrictions
as provided herein. 
 22. MISCELLANEOUS. 

(a) The rights and obligations of the Company under your Option shall be transferable to any one or more persons or entities, and all
covenants and agreements hereunder shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. 

(b) You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the
Company to carry out the purposes or intent of your Option. 
 (c) You acknowledge and agree that you have reviewed your Option in its
entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Option and fully understand all provisions of your Option. This Agreement and the Plan contain the entire agreement and understanding among the
parties as to the subject matter hereof, and supersede any other agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof (including, without limitation, the provisions in your employment letter
with respect thereto). 
 (d) This Agreement will be subject to all applicable laws, rules and regulations, and to such approvals by
any governmental agencies or national securities exchanges as may be required. 
 (e) All obligations of the Company under the Plan
and this Agreement will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation or otherwise, of all or substantially all of the business and/or assets
of the Company. 

 23. GOVERNING PLAN
DOCUMENT. Your Option is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your Option, and is further subject to all interpretations, amendments, rules and regulations,
which may from time to time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the provisions of your Option and those of the Plan, the provisions of the Plan shall control; provided, however, for avoidance
of doubt, terms contained in the Agreement but not in the Plan shall not constitute a conflict and such terms in the Agreement shall control. The Committee will have the power to interpret the Plan and this Agreement and to adopt such rules for the
administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee will be final and binding upon you,
the Company and all other interested persons. No member of the Board or the Committee will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement. 

24. EFFECT ON OTHER EMPLOYEE BENEFIT
PLANS. The value of the Award subject to this Agreement will not be included as compensation, earnings, salaries or other similar terms used when calculating the employee’s benefits under any employee benefit
plan sponsored by the Company or any affiliate except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify or terminate any of the Company’s or any affiliate’s employee benefit plans. 

25. CHOICE OF LAW. The interpretation, performance and enforcement of
this Agreement will be governed by the laws of the Province of Ontario and the laws of Canada. Each of the parties submits to the exclusive jurisdiction of the state courts within the State of New Jersey. In any issue, claim, demand, action, cause
of action, suit or proceeding arising out of, or relating to, this Agreement, each of the parties agrees that all claims in respect of the action or proceeding may be heard and determined in any such court, and agrees not to bring any action or
proceeding arising out of, relating to, based on or in connection with this Agreement in any other court. Each of the parties waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond,
surety or other security that might be required of any other party with respect thereto. 
 26.
SEVERABILITY. If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this
Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner that will give effect to the terms of such
Section or part of a Section to the fullest extent possible while remaining lawful and valid. 
 27.
[APPENDICES. Notwithstanding any provisions in this Agreement, the Option shall be subject to any special terms and conditions for employees outside the United States set forth in Appendix A and Appendix B
attached hereto (the “Appendices”). Further, if you relocate to one of the countries included in Appendix B, the special terms and conditions for such country will apply to you to the extent that the Company determines that the
application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Appendices constitutes part of this Agreement.]4 

 
  

	4 	 To be included as applicable. 

 28. ACKNOWLEDGEMENTS. By accepting this Award,
you hereby (i) acknowledge and agree that, notwithstanding anything to the contrary in any Employee Privacy Notice, and subject to the terms of Section 25 of the Plan, such Employee Privacy Notice shall apply to the Company’s and its
affiliates’ processing of your personal data in connection with the Plan and this Award, and (ii) consent to receive such documents by electronic delivery and to participate in the Plan through an
on-line or electronic system established and maintained by the Company or another third-party designated by the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]